1. Membrane Transporter/Ion Channel Neuronal Signaling
  2. Potassium Channel Calcium Channel
  3. UR 8225

UR 8225 is an orally active ATP-sensitive K+ channel activator with vasodilator, smooth muscle relaxant, antihypertensive, and bronchodilator activities. UR 8225 induces membrane hyperpolarization by increasing outward K+ conductance and reduces Ca2+ influx through voltage-gated L-type Ca2+ channels. UR 8225 reduces total peripheral vascular resistance, shortens cardiac action potential duration, inhibits agonist-induced Ca2+ influx, and stimulates renin release. UR 8225 induces reflex tachycardia but lacks β-adrenergic receptor blocking activity. UR 8225 is widely applicable to research in fields related to hypertension, myocardial ischemia, ventricular fibrillation, and other conditions.

For research use only. We do not sell to patients.

UR 8225

UR 8225 Chemical Structure

CAS No. : 149455-36-7

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

UR 8225 is an orally active ATP-sensitive K+ channel activator with vasodilator, smooth muscle relaxant, antihypertensive, and bronchodilator activities. UR 8225 induces membrane hyperpolarization by increasing outward K+ conductance and reduces Ca2+ influx through voltage-gated L-type Ca2+ channels. UR 8225 reduces total peripheral vascular resistance, shortens cardiac action potential duration, inhibits agonist-induced Ca2+ influx, and stimulates renin release. UR 8225 induces reflex tachycardia but lacks β-adrenergic receptor blocking activity. UR 8225 is widely applicable to research in fields related to hypertension, myocardial ischemia, ventricular fibrillation, and other conditions[1][2].

IC50 & Target

L-type calcium channel

 

In Vitro

UR 8225 (0.05-6.9 μM) inhibits spontaneous myogenic contractions (IC50=0.05 μM) and norepinephrine-induced contractions (IC50=6.9 μM) in rat portal vein segments, with effects antagonized by glyburide (HY-15206)[1].
UR 8225 (0.32-0.76 μM) relaxes spontaneous tone (EC50=0.32 μM) and inhibits histamine-induced contractions (EC50=0.76 μM) in isolated guinea pig trachea, with effects reversed by glyburide (HY-15206)[1].
UR 8225 (0.1-10 μM) concentration-dependently inhibits spontaneous contractile activity in guinea pig urinary bladder detrusor muscle, significantly reduces low KCl-induced contractions at 10 μM, and only slightly inhibits Carbamoylcholine chloride (HY-B1208)-induced contractions at 10 μM[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

UR 8225 (0.01-0.1 mg/kg; i.v.) acts as a potent bronchodilator in anesthetized guinea pigs, with an IC50 of 0.029 mg/kg for reducing metacholine-induced bronchoconstriction[1].
UR 8225 (0.1-1 mg/kg; p.o.) produces dose-dependent, long-lasting antihypertensive effects in conscious SHR with an ED20 of 0.1 mg/kg, accompanied by reflex tachycardia and transient activation of the renin-angiotensin system[1].
UR 8225 (0.03-0.3 mg/kg; i.v.) produces dose-dependent hypotensive effects in anesthetized normotensive rats with an ED20 of 0.04 mg/kg, and these effects are completely blocked by pretreatment with 20 mg/kg i.v. glyburide (HY-15206)[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male guinea pigs (anesthetized)[1]
Dosage: 0.01 mg/kg; 0.1 mg/kg
Administration: i.v.
Result: Produced a dose-related reduction in metacholine-induced bronchoconstriction, with an IC50 of 0.029 mg/kg.
Decreased metacholine-induced bronchospasm by 75.5% and reduced mean arterial blood pressure by 49.9%.
Animal Model: Normotensive rats (anesthetized)[1]
Dosage: 0.03 mg/kg; 0.1 mg/kg; 0.3 mg/kg
Administration: i.v.
Result: Produced dose-dependent reductions in MAP, with an ED20 of 0.04 mg/kg.
Decreased MAP by 43% at 0.1 mg/kg i.v.; this effect was reduced to 30%, 14%, and 0.4% by pretreatment with glyburide at 3 mg/kg, 10 mg/kg, and 20 mg/kg i.v., respectively, with 20 mg/kg glyburide completely blocking the hypotensive response.
Molecular Weight

290.32

Formula

C18H14N2O2

CAS No.
SMILES

N#CC1=CC2=C(C(C(C)(C)C=C2N3C=CC=CC3=O)=O)C=C1

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
UR 8225
Cat. No.:
HY-183206
Quantity:
MCE Japan Authorized Agent: